scholarly journals Composite large cell neuroendocrine carcinoma and adenocarcinoma of the common bile duct

2006 ◽  
Vol 59 (1) ◽  
pp. 105-107 ◽  
Author(s):  
K Sato
2014 ◽  
Vol 20 (47) ◽  
pp. 18048-18052 ◽  
Author(s):  
Sung Bae Park ◽  
Suk Bae Moon ◽  
Young Joon Ryu ◽  
Jeana Hong ◽  
Yang Hee Kim ◽  
...  

2016 ◽  
Vol 2 (1) ◽  
Author(s):  
Makoto Murakami ◽  
Kanji Katayama ◽  
Shigeru Kato ◽  
Daisuke Fujimoto ◽  
Mitsuhiro Morikawa ◽  
...  

2014 ◽  
Vol 2014 ◽  
pp. 1-4 ◽  
Author(s):  
John Wysocki ◽  
Rishi Agarwal ◽  
Laura Bratton ◽  
Jeremy Nguyen ◽  
Mandy Crause Weidenhaft ◽  
...  

Mixed adenoneuroendocrine carcinomas, spindle cell carcinomas, and clear cell carcinomas are all rare tumors in the biliary tract. We present the first case, to our knowledge, of an extrahepatic bile duct carcinoma composed of all three types. A 65-year-old man with prior cholecystectomy presented with painless jaundice, vomiting, and weight loss. CA19-9 and alpha-fetoprotein (AFP) were elevated. Cholangioscopy revealed a friable mass extending from the middle of the common bile duct to the common hepatic duct. A bile duct excision was performed. Gross examination revealed a 3.6 cm intraluminal polypoid tumor. Microscopically, the tumor had foci of conventional adenocarcinoma (CK7-positive and CA19-9-postive) surrounded by malignant-appearing spindle cells that were positive for cytokeratins and vimentin. Additionally, there were separate areas of large cell neuroendocrine carcinoma (LCNEC). Foci of clear cell carcinoma merged into both the LCNEC and the adenocarcinoma. Tumor invaded through the bile duct wall with extensive perineural and vascular invasion. Circumferential margins were positive. The patient’s poor performance status precluded adjuvant therapy and he died with recurrent and metastatic disease 5 months after surgery. This is consistent with the reported poor survival rates of biliary mixed adenoneuroendocrine carcinomas.


2017 ◽  
Vol 50 (1) ◽  
pp. 33-42
Author(s):  
Noriaki Kyogoku ◽  
Kazuhiro Iwai ◽  
Yasunori Yoshimi ◽  
Hayato Hosoi ◽  
Aya Matsui ◽  
...  

2009 ◽  
Vol 2 (4) ◽  
pp. 291-295 ◽  
Author(s):  
Toshihiko Kohashi ◽  
Yasuhiro Matsugu ◽  
Hideki Nakahara ◽  
Ichiro Ohmori ◽  
Hiroyuki Egi ◽  
...  

2021 ◽  
Vol 21 (1) ◽  
Author(s):  
Yoshitaka Kiya ◽  
Yuichi Nagakawa ◽  
Chie Takishita ◽  
Hiroaki Osakabe ◽  
Hitoe Nishino ◽  
...  

Abstract Background Cholangiocarcinoma is frequently observed in patients with congenital bile duct dilatation (CBDD). Most cholangiocarcinomas are adenocarcinomas. Other types, especially neuroendocrine carcinomas (NECs), are rare. To the best of our knowledge, this is the third reported case of an NEC of the common bile duct associated with CBDD and the first to receive adjuvant chemotherapy for advanced disease. Case presentation A 29-year-old woman presented with upper abdominal pain. Preoperative imaging indicated marked dilatation of the common bile duct and a tumor in the middle portion of the common bile duct. She was suspected of having distal cholangiocarcinoma associated with CBDD and underwent pylorus-preserving pancreaticoduodenectomy. Pathological and immunohistological findings led to a final diagnosis of large-cell NEC (pT3aN1M0 pStageIIB). The postoperative course was uneventful, and she was administered cisplatin and irinotecan every 4 weeks (four cycles) as adjuvant chemotherapy. She has remained recurrence-free for 16 months. Conclusions NEC might be a differential diagnosis in cases of cholangial tumor associated with congenital bile duct dilatation. This presentation is rare and valuable, and to establish better treatment for NEC, further reports are necessary.


2003 ◽  
Vol 42 (3) ◽  
pp. 235-238 ◽  
Author(s):  
Hirofumi SAKURAI ◽  
Akiko KAMIGAITO ◽  
Noriko HOSAKA

Sign in / Sign up

Export Citation Format

Share Document